Department of Pathology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
Intelligent Pathology Institute, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
Neuropathology. 2021 Feb;41(1):37-41. doi: 10.1111/neup.12695. Epub 2020 Sep 9.
Desmoplastic myxoid tumor (DMT), SMARCB1 mutant is a recently proposed new entity that mainly occurs in the pineal region and has epigenetic features similar to those of atypical teratoid/rhabdoid tumors (AT/RT)-MYC and poorly differentiated chordomas. Herein, we present a new case of a 33-year-old man with headaches, dizziness, nausea, vomiting, and blurred vision, who was initially found to have a suspicious germinoma on imaging. After surgical removal of the lesion, the postoperative pathological diagnosis was DMT, SMARCB1 mutant. To the best of our knowledge, this is the first case reported in China. Our findings also extend the range of the immunohistochemical phenotype of this rare tumor.
促纤维增生性黏液样肿瘤(DMT),SMARCB1 突变型是一种新提出的实体肿瘤,主要发生在松果体区,具有类似于非典型畸胎样/横纹肌样肿瘤(AT/RT)-MYC 和低分化脊索瘤的表观遗传学特征。在此,我们报告一例新的 33 岁男性病例,该患者头痛、头晕、恶心、呕吐和视力模糊,最初影像学检查发现可疑生殖细胞瘤。病变切除术后,术后病理诊断为 DMT,SMARCB1 突变型。据我们所知,这是中国首例报道。我们的研究结果还扩展了这种罕见肿瘤的免疫组织化学表型范围。